70 related articles for article (PubMed ID: 3803702)
1. Effect of esaprazole on gastric mucosal potential difference after oral administration of aspirin (ASA).
Ardizzone S; Sangaletti O; Ghirardosi C; Bianchi Porro G
J Int Med Res; 1986; 14(6):321-4. PubMed ID: 3803702
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of esaprazole activity on basal gastric secretion and on pentagastrin-stimulated secretion in healthy volunteers.
Erembourg L; Reggiani P; Tosi GP; Ferla G; Beinat L
Int J Clin Pharmacol Res; 1987; 7(2):95-100. PubMed ID: 3583500
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandins and gastric mucosal protection by esaprazole in rats.
Zuccari G; Clavenna G; Sala A; Viganò T; Crivellari MT; Folco G
Eur J Pharmacol; 1990 Oct; 187(1):19-25. PubMed ID: 2272352
[TBL] [Abstract][Full Text] [Related]
4. Esaprazole effect on acid, peptic and alkaline secretion in duodenal ulcer patients.
Dal Santo PL; Vianello F; Germana B; Dotto P; Laino G; Del Bianco T; Plebani M; Leandro G; Savarino V; Di Mario F
Z Gastroenterol; 1993 Jan; 31(1):11-4. PubMed ID: 8447149
[TBL] [Abstract][Full Text] [Related]
5. Persistent gastric-protective effect of antacid evaluated by measurement of transmucosal gastric potential difference.
Bergmann JF; Caulin C; Simoneau G; Dorf G; Segrestaa JM
Clin Pharmacol Ther; 1988 Nov; 44(5):546-9. PubMed ID: 3180636
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of acetaminophen against aspirin- and ethanol-induced damage to the human gastric mucosa.
Stern AI; Hogan DL; Kahn LH; Isenberg JI
Gastroenterology; 1984 Apr; 86(4):728-33. PubMed ID: 6698373
[TBL] [Abstract][Full Text] [Related]
7. Preventing acetylsalicylic acid damage to human gastric mucosa by use of prostaglandin E2.
Cohen MM; Clark L
Can J Surg; 1983 Mar; 26(2):116-8. PubMed ID: 6824996
[TBL] [Abstract][Full Text] [Related]
8. Phospholipid association reduces the gastric mucosal toxicity of aspirin in human subjects.
Anand BS; Romero JJ; Sanduja SK; Lichtenberger LM
Am J Gastroenterol; 1999 Jul; 94(7):1818-22. PubMed ID: 10406241
[TBL] [Abstract][Full Text] [Related]
9. Esaprazole, a new antiulcer agent, stimulates gastric mucus output in the rat.
Luzzani F; Clavenna G; Zuccari G
Drugs Exp Clin Res; 1989; 15(9):417-20. PubMed ID: 2630253
[TBL] [Abstract][Full Text] [Related]
10. Melatonin and its precursor L-tryptophan prevent acute gastric mucosal damage induced by aspirin in humans.
Konturek PC; Celinski K; Slomka M; Cichoz-Lach H; Burnat G; Naegel A; Bielanski W; Konturek JW; Konturek SJ
J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():67-75. PubMed ID: 18812629
[TBL] [Abstract][Full Text] [Related]
11. 3-Methoxy-5,7,3',4'-tetrahydroxyflavan (ME): a new compound to prevent gastric irritation. A gastric potential difference analysis.
Ganote DP; Hennings G; Lücker PW
Methods Find Exp Clin Pharmacol; 1983 Sep; 5(7):489-94. PubMed ID: 6668967
[TBL] [Abstract][Full Text] [Related]
12. [Esaprazole vs sulglicotide in the treatment of dyspeptic patients with chronic superficial gastritis of the antrum].
Sabbatini F; Minieri M; Castiglione F; Di Lanno E; Mazzacca G
Clin Ter; 1991 Apr; 137(2):83-9. PubMed ID: 1828408
[TBL] [Abstract][Full Text] [Related]
13. [Prolonged effect of an antacid treatment on changes in gastric potential difference induced by aspirin in man].
Bergmann JF; Simoneau G; Dorf G; Caulin C; Segrestaa JM
Therapie; 1989; 44(1):39-42. PubMed ID: 2734719
[TBL] [Abstract][Full Text] [Related]
14. [Protective effect of two antacids in acute acetylsalicylic acid-induced injuries to the human gastric mucosa].
Müller P; Dammann HG; Simon B
Arzneimittelforschung; 1985; 35(12):1862-4. PubMed ID: 3913424
[TBL] [Abstract][Full Text] [Related]
15. Cimetidine decreases aspirin-induced gastric mucosal damage in humans.
Hogan DL; Thomas FJ; Isenberg JI
Aliment Pharmacol Ther; 1987 Oct; 1(5):383-90. PubMed ID: 2979681
[TBL] [Abstract][Full Text] [Related]
16. Misoprostol attenuates aspirin-induced changes in potential difference and associated damage in canine gastric mucosa.
Gullikson GW; Anglin CP; Kessler LK; Smeach S; Bauer RF; Dajani EZ
Clin Invest Med; 1987 May; 10(3):145-51. PubMed ID: 3113798
[TBL] [Abstract][Full Text] [Related]
17. Esaprazole in the treatment of gastric ulcer: preliminary clinical trial.
Dal Monte PR; Gullini S; Saggioro A; Beinat L; Castiglioni CL
Drugs Exp Clin Res; 1987; 13(5):305-10. PubMed ID: 3315535
[TBL] [Abstract][Full Text] [Related]
18. Cell-kinetic alterations induced by aspirin in human gastric mucosa and their prevention by a cytoprotective agent.
Biasco G; Paganelli GM; Di Febo G; Siringo S; Barbara L
Digestion; 1992; 51(3):146-51. PubMed ID: 1521715
[TBL] [Abstract][Full Text] [Related]
19. [Prophylactic effect of Misoprostol on gastric lesions induced by aspirin (ASA) in healthy subjects].
Naves J; Santoyo R; Morales I
Rev Gastroenterol Mex; 1989; 54(4):203-6. PubMed ID: 2515571
[TBL] [Abstract][Full Text] [Related]
20. [Protective effect of misoprostol on the changes of transgastric potential difference induced by aspirin in man].
Bergmann JF; Simoneau G; Naudin R; Caulin C; Segrestaa JM
Rev Rhum Mal Osteoartic; 1991 Feb; 58(2):135-8. PubMed ID: 1904163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
